Panama Petrochem Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: March 16, 2026, 3:56 am

Market Cap	1,624 Cr.
Current Price	270
Intrinsic Value	₹241.05
High / Low	411/236
Stock P/E	8.75
Book Value	222
Dividend Yield	1.85 %
ROCE	20.4 %
ROE	15.9 %
Face Value	2.00
PEG Ratio	-2.07

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Panama Petrochem Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Panama Petrochem Ltd	1,624 Cr.	270	411/236	8.75	222	1.85 %	20.4 %	15.9 %	2.00
Thirumalai Chemicals Ltd	2,041 Cr.	169	329/158		127	0.00 %	0.26 %	4.13 %	1.00
Rossari Biotech Ltd	2,469 Cr.	446	768/443	17.9	226	0.11 %	15.8 %	12.2 %	2.00
Fineotex Chemical Ltd	2,563 Cr.	22.0	35.8/19.2	26.4	6.72	0.36 %	23.8 %	18.4 %	1.00
Camlin Fine Sciences Ltd	2,611 Cr.	136	335/128	1,100	46.3	0.00 %	11.0 %	15.0 %	1.00
Industry Average	11,964.40 Cr	691.00		76.41	182.87	0.52%	12.99%	25.41%	6.41

All Competitor Stocks of Panama Petrochem Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	573	510	530	574	512	741	671	699	728	695	693	773	775
Expenses	505	444	471	513	456	664	605	641	665	636	638	705	714
Operating Profit	68	66	58	61	56	77	66	58	63	59	55	69	61
OPM %	12%	13%	11%	11%	11%	10%	10%	8%	9%	9%	8%	9%	8%
Other Income	1	3	5	4	2	5	2	3	4	4	4	3	3
Interest	3	4	4	4	4	5	4	6	4	5	3	3	2
Depreciation	2	2	2	2	2	3	3	3	4	3	3	3	3
Profit before tax	64	63	57	58	52	74	61	53	59	55	53	65	58
Tax %	21%	19%	19%	20%	20%	17%	18%	16%	18%	20%	19%	18%	21%
Net Profit	50	51	46	47	41	61	50	44	48	44	43	53	46
EPS in Rs	8.29	8.40	7.59	7.76	6.84	10.08	8.29	7.29	8.02	7.32	7.05	8.76	7.57

Last Updated: March 3, 2026, 3:53 pm

Below is a detailed analysis of the quarterly data for Panama Petrochem Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

For Sales, as of Dec 2025, the value is 775.00 Cr.. The value appears strong and on an upward trend. It has increased from 773.00 Cr. (Sep 2025) to 775.00 Cr., marking an increase of 2.00 Cr..
For Expenses, as of Dec 2025, the value is 714.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 705.00 Cr. (Sep 2025) to 714.00 Cr., marking an increase of 9.00 Cr..
For Operating Profit, as of Dec 2025, the value is 61.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Sep 2025) to 61.00 Cr., marking a decrease of 8.00 Cr..
For OPM %, as of Dec 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Sep 2025) to 8.00%, marking a decrease of 1.00%.
For Other Income, as of Dec 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 3.00 Cr..
For Interest, as of Dec 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Sep 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
For Depreciation, as of Dec 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 3.00 Cr..
For Profit before tax, as of Dec 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 65.00 Cr. (Sep 2025) to 58.00 Cr., marking a decrease of 7.00 Cr..
For Tax %, as of Dec 2025, the value is 21.00%. The value appears to be increasing, which may not be favorable. It has increased from 18.00% (Sep 2025) to 21.00%, marking an increase of 3.00%.
For Net Profit, as of Dec 2025, the value is 46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Sep 2025) to 46.00 Cr., marking a decrease of 7.00 Cr..
For EPS in Rs, as of Dec 2025, the value is 7.57. The value appears to be declining and may need further review. It has decreased from 8.76 (Sep 2025) to 7.57, marking a decrease of 1.19.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 7:46 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	635	805	752	834	1,326	1,269	1,003	1,447	2,132	2,249	2,357	2,793	2,937
Expenses	604	773	704	759	1,219	1,169	950	1,257	1,836	1,940	2,103	2,546	2,693
Operating Profit	31	32	48	75	108	100	53	190	296	309	254	247	244
OPM %	5%	4%	6%	9%	8%	8%	5%	13%	14%	14%	11%	9%	8%
Other Income	1	1	2	4	2	3	4	6	6	7	14	12	14
Interest	6	8	8	9	14	25	17	9	7	12	18	18	13
Depreciation	2	3	5	5	5	6	7	8	8	9	10	12	13
Profit before tax	23	22	37	66	90	72	32	180	286	295	241	228	230
Tax %	22%	18%	31%	33%	32%	27%	10%	25%	20%	21%	19%	18%
Net Profit	18	18	25	44	61	52	29	135	230	233	195	187	186
EPS in Rs	2.92	2.93	4.16	7.24	10.08	8.58	4.76	22.37	38.08	38.51	32.26	30.92	30.70
Dividend Payout %	26%	46%	8%	9%	12%	14%	25%	9%	21%	21%	22%	10%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	0.00%	38.89%	76.00%	38.64%	-14.75%	-44.23%	365.52%	70.37%	1.30%	-16.31%	-4.10%
Change in YoY Net Profit Growth (%)	0.00%	38.89%	37.11%	-37.36%	-53.39%	-29.48%	409.75%	-295.15%	-69.07%	-17.61%	12.21%

Panama Petrochem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	13%
5 Years:	23%
3 Years:	9%
TTM:	13%

Compounded Profit Growth
10 Years:	27%
5 Years:	45%
3 Years:	-7%
TTM:	-10%

Stock Price CAGR
10 Years:	21%
5 Years:	41%
3 Years:	-2%
1 Year:	-27%

Return on Equity
10 Years:	20%
5 Years:	23%
3 Years:	20%
Last Year:	16%

Last Updated: September 5, 2025, 12:05 pm

Balance Sheet

Last Updated: December 4, 2025, 1:46 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	8	8	8	8	12	12	12	12	12	12	12	12	12
Reserves	231	241	264	305	359	402	421	549	756	940	1,091	1,243	1,328
Borrowings	17	42	57	33	45	160	51	66	30	0	26	33	31
Other Liabilities	205	207	162	323	559	346	273	366	455	282	281	236	262
Total Liabilities	461	498	492	669	976	919	757	993	1,253	1,235	1,409	1,524	1,633
Fixed Assets	77	119	123	125	134	156	173	185	230	248	287	312	310
CWIP	40	0	0	4	14	11	17	22	5	13	1	19	44
Investments	0	0	2	1	0	0	0	0	5	4	2	19	42
Other Assets	345	379	366	538	828	752	567	785	1,013	970	1,120	1,174	1,237
Total Assets	461	498	492	669	976	919	757	993	1,253	1,235	1,409	1,524	1,633

Below is a detailed analysis of the balance sheet data for Panama Petrochem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
For Reserves, as of Sep 2025, the value is 1,328.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,243.00 Cr. (Mar 2025) to 1,328.00 Cr., marking an increase of 85.00 Cr..
For Borrowings, as of Sep 2025, the value is 31.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 33.00 Cr. (Mar 2025) to 31.00 Cr., marking a decrease of 2.00 Cr..
For Other Liabilities, as of Sep 2025, the value is 262.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 236.00 Cr. (Mar 2025) to 262.00 Cr., marking an increase of 26.00 Cr..
For Total Liabilities, as of Sep 2025, the value is 1,633.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,524.00 Cr. (Mar 2025) to 1,633.00 Cr., marking an increase of 109.00 Cr..
For Fixed Assets, as of Sep 2025, the value is 310.00 Cr.. The value appears to be declining and may need further review. It has decreased from 312.00 Cr. (Mar 2025) to 310.00 Cr., marking a decrease of 2.00 Cr..
For CWIP, as of Sep 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 25.00 Cr..
For Investments, as of Sep 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 23.00 Cr..
For Other Assets, as of Sep 2025, the value is 1,237.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,174.00 Cr. (Mar 2025) to 1,237.00 Cr., marking an increase of 63.00 Cr..
For Total Assets, as of Sep 2025, the value is 1,633.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,524.00 Cr. (Mar 2025) to 1,633.00 Cr., marking an increase of 109.00 Cr..

Notably, the Reserves (1,328.00 Cr.) exceed the Borrowings (31.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	30	-12	18	59	34	-78	179	56	170	210	-28	162
Cash from Investing Activity +	-36	-13	-12	-21	-14	-22	-20	-15	-111	-79	66	-12
Cash from Financing Activity +	-23	11	-2	-36	-6	81	-136	-1	-67	-96	-40	-78
Net Cash Flow	-29	-14	4	2	14	-19	23	40	-9	35	-2	72

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	14.00	-10.00	-9.00	42.00	63.00	-60.00	2.00	124.00	266.00	309.00	228.00	214.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	96	79	75	80	77	90	91	82	54	57	63	66
Inventory Days	84	86	93	161	145	134	111	122	108	68	93	65
Days Payable	123	97	85	164	173	110	112	110	94	55	46	33
Cash Conversion Cycle	58	68	82	77	49	114	90	94	68	70	109	97
Working Capital Days	58	52	61	66	51	66	76	73	68	77	107	100
ROCE %	12%	11%	15%	22%	27%	20%	9%	34%	41%	35%	24%	20%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	69.87%	69.87%	69.25%	67.30%	65.83%	61.94%	61.94%	61.94%	61.94%	62.22%	62.51%	63.16%
FIIs	3.20%	3.45%	5.83%	8.31%	10.03%	14.88%	14.71%	15.77%	12.44%	12.07%	12.02%	11.29%
DIIs	0.00%	0.00%	0.04%	0.01%	0.01%	0.26%	0.06%	0.05%	0.29%	0.35%	0.47%	0.67%
Public	26.93%	26.69%	24.89%	24.36%	24.10%	22.92%	23.28%	22.24%	25.32%	25.36%	24.99%	24.86%
No. of Shareholders	24,148	24,291	26,456	27,218	26,633	25,125	27,275	26,145	25,412	24,952	25,951	26,068

Shareholding Pattern Chart

No. of Shareholders

Panama Petrochem Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	2.00	2.00	2.00	2.00	2.00
Basic EPS (Rs.)	30.92	32.26	38.51	38.08	22.37
Diluted EPS (Rs.)	30.92	32.26	38.51	38.08	22.37
Cash EPS (Rs.)	32.96	33.88	40.07	39.47	23.63
Book Value[Excl.RevalReserv]/Share (Rs.)	207.44	182.27	157.37	126.99	92.73
Book Value[Incl.RevalReserv]/Share (Rs.)	207.44	182.27	157.37	126.99	92.73
Revenue From Operations / Share (Rs.)	461.63	389.54	371.69	352.49	239.19
PBDIT / Share (Rs.)	42.80	44.39	52.16	49.88	32.41
PBIT / Share (Rs.)	40.75	42.77	50.60	48.49	31.15
PBT / Share (Rs.)	37.75	39.80	48.69	47.32	29.67
Net Profit / Share (Rs.)	30.91	32.26	38.51	38.08	22.37
NP After MI And SOA / Share (Rs.)	30.91	32.26	38.51	38.08	22.37
PBDIT Margin (%)	9.27	11.39	14.03	14.14	13.55
PBIT Margin (%)	8.82	10.97	13.61	13.75	13.02
PBT Margin (%)	8.17	10.21	13.09	13.42	12.40
Net Profit Margin (%)	6.69	8.28	10.36	10.80	9.35
NP After MI And SOA Margin (%)	6.69	8.28	10.36	10.80	9.35
Return on Networth / Equity (%)	14.90	17.69	24.46	29.98	24.12
Return on Capital Employeed (%)	18.99	23.17	31.78	37.73	32.98
Return On Assets (%)	12.27	13.84	18.86	18.38	13.63
Total Debt / Equity (X)	0.00	0.02	0.00	0.03	0.11
Asset Turnover Ratio (%)	1.90	1.78	1.49	1.48	1.53
Current Ratio (X)	5.18	3.81	3.56	2.13	1.86
Quick Ratio (X)	3.37	2.13	2.37	1.10	0.99
Inventory Turnover Ratio (X)	6.20	5.78	3.40	2.83	3.49
Dividend Payout Ratio (NP) (%)	19.40	24.79	23.36	10.50	0.00
Dividend Payout Ratio (CP) (%)	18.20	23.60	22.45	10.13	0.00
Earning Retention Ratio (%)	80.60	75.21	76.64	89.50	0.00
Cash Earning Retention Ratio (%)	81.80	76.40	77.55	89.87	0.00
Interest Coverage Ratio (X)	14.26	14.95	27.27	42.75	21.92
Interest Coverage Ratio (Post Tax) (X)	11.30	11.87	21.14	33.64	16.13
Enterprise Value (Cr.)	2124.06	1894.57	1541.82	1494.48	870.27
EV / Net Operating Revenue (X)	0.76	0.80	0.68	0.70	0.60
EV / EBITDA (X)	8.20	7.05	4.89	4.95	4.44
MarketCap / Net Operating Revenue (X)	0.82	0.84	0.78	0.75	0.60
Retention Ratios (%)	80.59	75.20	76.63	89.49	0.00
Price / BV (X)	1.84	1.82	1.85	2.09	1.57
Price / Net Operating Revenue (X)	0.82	0.84	0.78	0.75	0.60
EarningsYield	0.08	0.09	0.13	0.14	0.15

After reviewing the key financial ratios for Panama Petrochem Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 25, the value is 30.92. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.92, marking a decrease of 1.34.
For Diluted EPS (Rs.), as of Mar 25, the value is 30.92. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.92, marking a decrease of 1.34.
For Cash EPS (Rs.), as of Mar 25, the value is 32.96. This value is within the healthy range. It has decreased from 33.88 (Mar 24) to 32.96, marking a decrease of 0.92.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 207.44. It has increased from 182.27 (Mar 24) to 207.44, marking an increase of 25.17.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 207.44. It has increased from 182.27 (Mar 24) to 207.44, marking an increase of 25.17.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 461.63. It has increased from 389.54 (Mar 24) to 461.63, marking an increase of 72.09.
For PBDIT / Share (Rs.), as of Mar 25, the value is 42.80. This value is within the healthy range. It has decreased from 44.39 (Mar 24) to 42.80, marking a decrease of 1.59.
For PBIT / Share (Rs.), as of Mar 25, the value is 40.75. This value is within the healthy range. It has decreased from 42.77 (Mar 24) to 40.75, marking a decrease of 2.02.
For PBT / Share (Rs.), as of Mar 25, the value is 37.75. This value is within the healthy range. It has decreased from 39.80 (Mar 24) to 37.75, marking a decrease of 2.05.
For Net Profit / Share (Rs.), as of Mar 25, the value is 30.91. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.91, marking a decrease of 1.35.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 30.91. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.91, marking a decrease of 1.35.
For PBDIT Margin (%), as of Mar 25, the value is 9.27. This value is below the healthy minimum of 10. It has decreased from 11.39 (Mar 24) to 9.27, marking a decrease of 2.12.
For PBIT Margin (%), as of Mar 25, the value is 8.82. This value is below the healthy minimum of 10. It has decreased from 10.97 (Mar 24) to 8.82, marking a decrease of 2.15.
For PBT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has decreased from 10.21 (Mar 24) to 8.17, marking a decrease of 2.04.
For Net Profit Margin (%), as of Mar 25, the value is 6.69. This value is within the healthy range. It has decreased from 8.28 (Mar 24) to 6.69, marking a decrease of 1.59.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.69. This value is below the healthy minimum of 8. It has decreased from 8.28 (Mar 24) to 6.69, marking a decrease of 1.59.
For Return on Networth / Equity (%), as of Mar 25, the value is 14.90. This value is below the healthy minimum of 15. It has decreased from 17.69 (Mar 24) to 14.90, marking a decrease of 2.79.
For Return on Capital Employeed (%), as of Mar 25, the value is 18.99. This value is within the healthy range. It has decreased from 23.17 (Mar 24) to 18.99, marking a decrease of 4.18.
For Return On Assets (%), as of Mar 25, the value is 12.27. This value is within the healthy range. It has decreased from 13.84 (Mar 24) to 12.27, marking a decrease of 1.57.
For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
For Asset Turnover Ratio (%), as of Mar 25, the value is 1.90. It has increased from 1.78 (Mar 24) to 1.90, marking an increase of 0.12.
For Current Ratio (X), as of Mar 25, the value is 5.18. This value exceeds the healthy maximum of 3. It has increased from 3.81 (Mar 24) to 5.18, marking an increase of 1.37.
For Quick Ratio (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 2. It has increased from 2.13 (Mar 24) to 3.37, marking an increase of 1.24.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.20. This value is within the healthy range. It has increased from 5.78 (Mar 24) to 6.20, marking an increase of 0.42.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.40. This value is below the healthy minimum of 20. It has decreased from 24.79 (Mar 24) to 19.40, marking a decrease of 5.39.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 18.20. This value is below the healthy minimum of 20. It has decreased from 23.60 (Mar 24) to 18.20, marking a decrease of 5.40.
For Earning Retention Ratio (%), as of Mar 25, the value is 80.60. This value exceeds the healthy maximum of 70. It has increased from 75.21 (Mar 24) to 80.60, marking an increase of 5.39.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 81.80. This value exceeds the healthy maximum of 70. It has increased from 76.40 (Mar 24) to 81.80, marking an increase of 5.40.
For Interest Coverage Ratio (X), as of Mar 25, the value is 14.26. This value is within the healthy range. It has decreased from 14.95 (Mar 24) to 14.26, marking a decrease of 0.69.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.30. This value is within the healthy range. It has decreased from 11.87 (Mar 24) to 11.30, marking a decrease of 0.57.
For Enterprise Value (Cr.), as of Mar 25, the value is 2,124.06. It has increased from 1,894.57 (Mar 24) to 2,124.06, marking an increase of 229.49.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.76, marking a decrease of 0.04.
For EV / EBITDA (X), as of Mar 25, the value is 8.20. This value is within the healthy range. It has increased from 7.05 (Mar 24) to 8.20, marking an increase of 1.15.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.82, marking a decrease of 0.02.
For Retention Ratios (%), as of Mar 25, the value is 80.59. This value exceeds the healthy maximum of 70. It has increased from 75.20 (Mar 24) to 80.59, marking an increase of 5.39.
For Price / BV (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has increased from 1.82 (Mar 24) to 1.84, marking an increase of 0.02.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.82, marking a decrease of 0.02.
For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.08, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Panama Petrochem Ltd as of March 16, 2026 is: ₹251.66

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 16, 2026, Panama Petrochem Ltd is Overvalued by 6.79% compared to the current share price ₹270.00

Intrinsic Value of Panama Petrochem Ltd as of March 16, 2026 is: ₹241.05

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 16, 2026, Panama Petrochem Ltd is Overvalued by 10.72% compared to the current share price ₹270.00

Last 5 Year EPS CAGR: -4.22%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 22.50%, which is a positive sign. The company has higher reserves (625.38 cr) compared to borrowings (45.46 cr), indicating strong financial stability. The company has shown consistent growth in sales (233.85 cr) and profit (138.62 cr) over the years.	The stock has a high average Working Capital Days of 71.25, which may not be favorable. The stock has a high average Cash Conversion Cycle of 81.33, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Panama Petrochem Ltd:
1. Net Profit Margin: 6.69%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 18.99% (Industry Average ROCE: 12.99%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 14.9% (Industry Average ROE: 25.41%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 11.3
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 3.37
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 8.75 (Industry average Stock P/E: 76.41)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Panama Petrochem Ltd. is a Public Limited Listed company incorporated on 09/03/1982 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L23209GJ1982PLC005062 and registration number is 005062. Currently Company is involved in the business activities of Manufacture of refined petroleum products. Company's Total Operating Revenue is Rs. 1775.72 Cr. and Equity Capital is Rs. 12.10 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Lubricants	Plot No. 3303, Ankleshwar Gujarat 393002	Contact not found

Management
Name	Position Held
Mr. Amirali E Rayani	Executive Chairman
Mr. Samir A Rayani	Managing Director & CEO
Mr. Hussein V Rayani	Joint Managing Director
Mr. Arif A Rayani	Executive Director
Mr. Kumar Raju Nandimandalam	Ind. Non-Executive Director
Mr. Ashok Mukhi	Ind. Non-Executive Director
Mr. Arvind Shah	Ind. Non-Executive Director
Ms. Almas Nanda	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Panama Petrochem Ltd?

Panama Petrochem Ltd's intrinsic value (as of 16 March 2026) is ₹241.05 which is 10.72% lower the current market price of ₹270.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,624 Cr. market cap, FY2025-2026 high/low of ₹411/236, reserves of ₹1,328 Cr, and liabilities of ₹1,633 Cr.

What is the Market Cap of Panama Petrochem Ltd?

The Market Cap of Panama Petrochem Ltd is 1,624 Cr..

What is the current Stock Price of Panama Petrochem Ltd as on 16 March 2026?

The current stock price of Panama Petrochem Ltd as on 16 March 2026 is ₹270.

What is the High / Low of Panama Petrochem Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Panama Petrochem Ltd stocks is ₹411/236.

What is the Stock P/E of Panama Petrochem Ltd?

The Stock P/E of Panama Petrochem Ltd is 8.75.

What is the Book Value of Panama Petrochem Ltd?

The Book Value of Panama Petrochem Ltd is 222.

What is the Dividend Yield of Panama Petrochem Ltd?

The Dividend Yield of Panama Petrochem Ltd is 1.85 %.

What is the ROCE of Panama Petrochem Ltd?

The ROCE of Panama Petrochem Ltd is 20.4 %.

What is the ROE of Panama Petrochem Ltd?

The ROE of Panama Petrochem Ltd is 15.9 %.

What is the Face Value of Panama Petrochem Ltd?

The Face Value of Panama Petrochem Ltd is 2.00.